Sub-Total: $0.00
Emerging Strategies in the Management of Chronic Fibrosing ILD Patients Who Have Contracted COVID-19
Complimentary
Released on 10/28/20
Expires on 10/28/21
Description
Related products
-
Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more -
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more -
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more -
New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Read more
